Search

Your search keyword '"Villarroel, Paola Mariela Saba"' showing total 20 results
Start Over Author "Villarroel, Paola Mariela Saba"
20 results on '"Villarroel, Paola Mariela Saba"'

1. SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave

Author

Pouquet, Marie, Decarreaux, Dorine, Di Domenico, Laura, Sabbatini, Chiara E., Prévot-Monsacre, Pol, Fourié, Toscane, Villarroel, Paola Mariela Saba, Priet, Stephane, Blanché, Hélène, Sebaoun, Jean-Marc, Deleuze, Jean-François, Turbelin, Clément, Rossignol, Louise, Werner, Andréas, Kochert, Fabienne, Grosgogeat, Brigitte, Rabiega, Pascaline, Laupie, Julien, Abraham, Nathalie, Noël, Harold, van der Werf, Sylvie, Colizza, Vittoria, Carrat, Fabrice, Charrel, Remi, de Lamballerie, Xavier, Blanchon, Thierry, and Falchi, Alessandra

Published
2024
Full Text
View/download PDF

2. Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages

Author

Driouich, Jean-Sélim, Cochin, Maxime, Lingas, Guillaume, Luciani, Léa, Baronti, Cécile, Bernadin, Ornéllie, Gilles, Magali, Villarroel, Paola Mariela Saba, Moureau, Grégory, Petit, Paul-Rémi, Dupont, Axelle, Izopet, Jacques, Kamar, Nassim, Autran, Brigitte, Paintaud, Gilles, Caillard, Sophie, le Bourgeois, Amandine, Richez, Christophe, Couzi, Lionel, Xhaard, Aliénor, Marjanovic, Zora, Avouac, Jerome, Jacquet, Caroline, Anglicheau, Dany, Cheminant, Morgane, Nguyen, Stéphanie, Terrier, Benjamin, Gottenberg, Jacques Eric, Besson, Caroline, Letrou, Sophie, Tine, Josephine, Basilua, Joe Miantezila, Angoulvant, Denis, Tardivon, Coralie, Blancho, Gilles, Martin-Blondel, Guillaume, Yazdanpanah, Yazdan, Mentré, France, Lévy, Vincent, Touret, Franck, Guedj, Jérémie, de Lamballerie, Xavier, and Nougairède, Antoine

Published
2024
Full Text
View/download PDF

7. Severe fever with thrombocytopenia syndrome virus (SFTSV) in Thailand: Seroprevalence study in humans and molecular detection in ticks

Author

Villarroel, Paola Mariela Saba, primary, Chaiphongpachara, Tanawat, additional, Nurtop, Elif, additional, Laojun, Sedthapong, additional, Pangpoo-nga, Tassanee, additional, Songhong, Thanaphon, additional, Supungul, Dolruethai, additional, Baronti, Cécile, additional, Thirion, Laurence, additional, Leaungwutiwong, Pornsawan, additional, de Lamballerie, Xavier, additional, Missé, Dorothée, additional, and Wichit, Sineewanlaya, additional

Published
2024
Full Text
View/download PDF

10. Orthopoxvirus Seroprevalence and Infection Susceptibility in France, Bolivia, Laos, and Mali

Author

Luciani, Léa, primary, Lapidus, Nathanaël, additional, Amroun, Abdennour, additional, Falchi, Alessandra, additional, Souksakhone, Chanthala, additional, Mayxay, Mayfong, additional, Dubot-Pérès, Audrey, additional, Villarroel, Paola Mariela Saba, additional, Diarra, Issa, additional, Koita, Ousmane, additional, Gallian, Pierre, additional, and de Lamballerie, Xavier, additional

Published
2022
Full Text
View/download PDF

11. Eight Months of Serological Follow-Up of Anti-SARS-CoV-2 Antibodies in France: A Study among an Adult Population

Author

Decarreaux, Dorine, primary, Sevila, Julie, additional, Masse, Shirley, additional, Capai, Lisandru, additional, Fourié, Toscane, additional, Villarroel, Paola Mariela Saba, additional, Amroun, Abdennour, additional, Nurtop, Elif, additional, Vareille, Matthieu, additional, Blanchon, Thierry, additional, de Lamballerie, Xavier, additional, Charrel, Remi, additional, and Falchi, Alessandra, additional

Published
2022
Full Text
View/download PDF

13. Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France

Author

Decarreaux, Dorine, primary, Pouquet, Marie, additional, Souty, Cecile, additional, Vilcu, Ana-Maria, additional, Prévot-Monsacre, Pol, additional, Fourié, Toscane, additional, Villarroel, Paola Mariela Saba, additional, Priet, Stephane, additional, Blanché, Hélène, additional, Sebaoun, Jean-Marc, additional, Deleuze, Jean-François, additional, Turbelin, Clément, additional, Werner, Andréas, additional, Kochert, Fabienne, additional, Grosgogeat, Brigitte, additional, Rabiega, Pascaline, additional, Laupie, Julien, additional, Abraham, Nathalie, additional, Guerrisi, Caroline, additional, Noël, Harold, additional, Van der Werf, Sylvie, additional, Carrat, Fabrice, additional, Hanslik, Thomas, additional, Charrel, Remi, additional, De Lamballerie, Xavier, additional, Blanchon, Thierry, additional, and Falchi, Alessandra, additional

Published
2022
Full Text
View/download PDF

15. Activity of Tixagevimab/Cilgavimab against the Omicron variant of SARS-CoV-2 in a hamster model

Author

DRIOUICH, Jean-Sélim, primary, Lingas, Guillaume, additional, Luciani, Léa, additional, Cochin, Maxime, additional, Villarroel, Paola Mariela Saba, additional, Moureau, Gregory, additional, Petit, Paul Rémi, additional, Touret, Franck, additional, Guedj, Jeremie, additional, de Lamballerie, Xavier, additional, and Nougairède, Antoine, additional

Published
2022
Full Text
View/download PDF

16. Spike and neutralizing antibodies response to COVID-19 vaccination in haemodialysis patients

Author

Giot, Matthieu, primary, Fourié, Toscane, additional, Lano, Guillaume, additional, Villarroel, Paola Mariela Saba, additional, Lamballeri, Xavier de, additional, Gully, Marion, additional, Samson, Laurent, additional, Farault, Julien, additional, Bouchouareb, Dammar, additional, Jehel, Océane, additional, Brunet, Philippe, additional, Jourde-Chiche, Noémie, additional, Ninove, Laetitia, additional, and Robert, Thomas, additional

Published
2021
Full Text
View/download PDF

17. Seroprevalence of SARS-CoV-2 Among Adults in Three Regions of France Following the Lockdown and Associated Risk Factors: A Multicohort Study

Author

Carrat, Fabrice, primary, de Lamballerie, Xavier, additional, Rahib, Delphine, additional, Blanché, Hélène, additional, Lapidus, Nathanael, additional, Artaud, Fanny, additional, Kab, Sofiane, additional, Renuy, Adeline, additional, de Edelenyi, Fabien Szabo, additional, Meyer, Laurence, additional, Lydié, Nathalie, additional, Charles, Marie-Aline, additional, Ancel, Pierre-Yves, additional, Jusot, Florence, additional, Rouquette, Alexandra, additional, Priet, Stéphane, additional, Villarroel, Paola Mariela Saba, additional, Fourié, Toscane, additional, Lusivika-Nzinga, Clovis, additional, Nicol, Jerome, additional, Legot, Stephane, additional, Druesne-Pecollo, Nathalie, additional, Esseddik, Younes, additional, Lai, Cindy, additional, Gagliolo, Jean-Marie, additional, Deleuze, Jean-François, additional, Bajos, Nathalie, additional, Severi, Gianluca, additional, Touvier, Mathilde, additional, Zins, Marie, additional, and Groups, SAPRIS and SAPRIS-SERO Study, additional

Published
2020
Full Text
View/download PDF

18. Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study.

Author

Carrat, Fabrice, Lamballerie, Xavier de, Rahib, Delphine, Blanché, Hélène, Lapidus, Nathanael, Artaud, Fanny, Kab, Sofiane, Renuy, Adeline, Edelenyi, Fabien Szabo de, Meyer, Laurence, Lydié, Nathalie, Charles, Marie-Aline, Ancel, Pierre-Yves, Jusot, Florence, Rouquette, Alexandra, Priet, Stéphane, Villarroel, Paola Mariela Saba, Fourié, Toscane, Lusivika-Nzinga, Clovis, and Nicol, Jérôme

Subjects
ADULTS, SARS-CoV-2, STAY-at-home orders, COVID-19, SEROCONVERSION
Abstract

Background: We aimed to estimate the seropositivity to anti-SARS-CoV-2 antibodies in May-June 2020 after the first lockdown period in adults living in three regions in France and to identify the associated risk factors.Methods: Between 4 May 2020 and 23 June 2020, 16 000 participants in a survey on COVID-19 from an existing consortium of three general adult population cohorts living in the Ile-de-France (IDF) or Grand Est (GE) (two regions with high rate of COVID-19) or in the Nouvelle-Aquitaine (NA) (with a low rate) were randomly selected to take a dried-blood spot for anti-SARS-CoV-2 antibodies assessment with three different serological methods (ClinicalTrial Identifier #NCT04392388). The primary outcome was a positive anti-SARS-CoV-2 ELISA IgG result against the spike protein of the virus (ELISA-S). Estimates were adjusted using sampling weights and post-stratification methods. Multiple imputation was used to infer the cumulative incidence of SARS-CoV-2 infection with adjustments for imperfect tests accuracies.Results: The analysis included 14 628 participants, 983 with a positive ELISA-S. The weighted estimates of seropositivity and cumulative incidence were 10.0% [95% confidence interval (CI): 9.1%, 10.9%] and 11.4% (95% CI: 10.1%, 12.8%) in IDF, 9.0% (95% CI: 7.7%, 10.2%) and 9.8% (95% CI: 8.1%, 11.8%) in GE and 3.1% (95% CI: 2.4%, 3.7%) and 2.9% (95% CI: 2.1%, 3.8%) in NA, respectively. Seropositivity was higher in younger participants [odds ratio (OR) = 1.84 (95% CI: 1.79, 6.09) in <40 vs 50-60 years old and OR = 0.56 (95% CI: 0.42, 0.74) in ≥70 vs 50-60 years old)] and when at least one child or adolescent lived in the same household [OR = 1.30 (95% CI: 1.11, 1.53)] and was lower in smokers compared with non-smokers [OR = 0.71 (95% CI: 0.57, 0.49)].Conclusions: Seropositivity to anti-SARS-CoV-2 antibodies in the French adult population was ≤10% after the first wave. Modifiable and non-modifiable risk factors were identified. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

19. Study protocol for the multicentre cohorts of Zika virus infection in pregnant women, infants, and acute clinical cases in Latin America and the Caribbean: the ZIKAlliance consortium

Author

Avelino-Silva, Vivian I., Mayaud, Philippe, Tami, Adriana, Miranda, Maria C., Rosenberger, Kerstin D., Alexander, Neal, Nacul, Luis, Segurado, Aluisio, Pohl, Moritz, Bethencourt, Sarah, Villar, Luis A., Viana, Isabelle F.T., Rabello, Renata, Soria, Carmen, Salgado, Silvia P., Gotuzzo, Eduardo, Guzmán, María G., Martínez, Pedro A., López-Gatell, Hugo, Hegewisch-Taylor, Jennifer, Borja-Aburto, Victor H., Gonzalez, Cesar, Netto, Eduardo M., Saba Villarroel, Paola M., Hoen, Bruno, Brasil, Patrícia, Marques, Ernesto T.A., Rockx, Barry, Koopmans, Marion, De Lamballerie, Xavier, Jaenisch, Thomas, Rosenberger, Kerstin Daniela, Morales, Ivonne, Tobian, Frank, Uhlmann, Lorenz, Schretzmann, Julius, Leege, Annika, Lins, Roberto D., De Filippis, Ana Maria Bispo, Duarte, Ana Claudia Machado, De Melo Espíndola, Otavio, Bonaldo, Myrna, Damasceno, Luana, Avelino-Silva, Vivian, Sabino, Ester, Mendes-Correa, Maria Cassia, Netto, Eduardo Martins, Falcon, Cristel, Rodríguez, Egri, Matos, Victmar, Tinedo, Maria José, La Rosa, Yenifer, Murillo, Marianela, Villar, Luis Angel, Miranda, Maria Consuelo, Lozano, Anyela, Herrera, Victor Mauricio, Gomez, Adriana, Gelvez, Rosa Margarita, Ortiz, Ricardo, Dimitrakis, Lady, Salgado, Silvia Paola, Arrata, Mary Regato, Allison, Humberto Guerra, Talledo, Michael, Villarroel, Paola Mariela Saba, Torres, Eric Martínez, Martínez Rodríguez, Pedro A., Vera, Mayling Alvarez, Santana, Belkis Galindo, Reyes, Alicia, Álvarez, Silvia Serrano, Dorticós, Diana Ferriol, Alpuche-Aranda, Celia, González-Diaz, Esteban, Pavía-Ruz, Norma, Borja-Aburto, Victor Hugo, Grajales, Concepción, Rojas, Teresita, Arriaga, Lumumba, Vallejos, Alfonso, Tynevez, Dominique, Thirion, Laurence, Drexler, Jan Felix, Van Gorp, Eric, Virology, Microbes in Health and Disease (MHD), London School of Hygiene and Tropical Medicine (LSHTM), Department of Telecomunication and Control, Universidade de São Paulo (USP), Instituto Pirenaico de Ecologia (IPE), Consejo Superior de Investigaciones Científicas [Madrid] (CSIC), Instituto de Medicina Tropical 'Alexander von Humboldt' (IMT AvH), Universidad Peruana Cayetano Heredia (UPCH), Pedro Kouri Institute of Tropical Medicine, Fundação Oswaldo Cruz (FIOCRUZ), Réseau International des Instituts Pasteur (RIIP), Erasmus University Medical Center [Rotterdam] (Erasmus MC), Department of Viroscience [Rotterdam, The Netherlands], Unité des Virus Emergents (UVE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Heidelberg University Hospital [Heidelberg], Universidade de São Paulo = University of São Paulo (USP), Instituto Pirenaico de Ecologìa = Pyrenean Institute of Ecology [Zaragoza] (IPE - CSIC), and Fundação Oswaldo Cruz / Oswaldo Cruz Foundation (FIOCRUZ)

Subjects
Pediatrics, [SDV]Life Sciences [q-bio], Abortion, Zika virus, Miscarriage, Dengue fever, Congenital abnormalities, Cohort Studies, Study Protocol, 0302 clinical medicine, Pregnancy, Seroepidemiologic Studies, Medicine, 030212 general & internal medicine, Prospective Studies, Pregnancy Complications, Infectious, Child, Children, biology, Coinfection, Zika Virus Infection, Incidence (epidemiology), Cohort, Prenatal Care, Mosquito-borne viruses, 3. Good health, Infectious Diseases, Caribbean Region, Child, Preschool, Microcephaly, Female, Cohort study, Adult, Risk, medicine.medical_specialty, 030231 tropical medicine, Natural history, lcsh:Infectious and parasitic diseases, 03 medical and health sciences, Zika, SDG 3 - Good Health and Well-being, Humans, lcsh:RC109-216, Caribbean, business.industry, Pregnant women, Infant, Zika Virus, medicine.disease, biology.organism_classification, Vector-borne viruses, Latin America, business, Arboviruses, Follow-Up Studies
Abstract

Background The European Commission (EC) Horizon 2020 (H2020)-funded ZIKAlliance Consortium designed a multicentre study including pregnant women (PW), children (CH) and natural history (NH) cohorts. Clinical sites were selected over a wide geographic range within Latin America and the Caribbean, taking into account the dynamic course of the ZIKV epidemic. Methods Recruitment to the PW cohort will take place in antenatal care clinics. PW will be enrolled regardless of symptoms and followed over the course of pregnancy, approximately every 4 weeks. PW will be revisited at delivery (or after miscarriage/abortion) to assess birth outcomes, including microcephaly and other congenital abnormalities according to the evolving definition of congenital Zika syndrome (CZS). After birth, children will be followed for 2 years in the CH cohort. Follow-up visits are scheduled at ages 1–3, 4–6, 12, and 24 months to assess neurocognitive and developmental milestones. In addition, a NH cohort for the characterization of symptomatic rash/fever illness was designed, including follow-up to capture persisting health problems. Blood, urine, and other biological materials will be collected, and tested for ZIKV and other relevant arboviral diseases (dengue, chikungunya, yellow fever) using RT-PCR or serological methods. A virtual, decentralized biobank will be created. Reciprocal clinical monitoring has been established between partner sites. Substudies of ZIKV seroprevalence, transmission clustering, disabilities and health economics, viral kinetics, the potential role of antibody enhancement, and co-infections will be linked to the cohort studies. Discussion Results of these large cohort studies will provide better risk estimates for birth defects and other developmental abnormalities associated with ZIKV infection including possible co-factors for the variability of risk estimates between other countries and regions. Additional outcomes include incidence and transmission estimates of ZIKV during and after pregnancy, characterization of short and long-term clinical course following infection and viral kinetics of ZIKV. Study registrations clinicaltrials.gov NCT03188731 (PW cohort), June 15, 2017; clinicaltrials.gov NCT03393286 (CH cohort), January 8, 2018; clinicaltrials.gov NCT03204409 (NH cohort), July 2, 2017.

Published
2018

20. Corrigendum to: Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study.

Author

Carrat, Fabrice, Lamballerie, Xavier de, Rahib, Delphine, Blanché, Hélène, Lapidus, Nathanael, Artaud, Fanny, Kab, Sofiane, Renuy, Adeline, Edelenyi, Fabien Szabo de, Meyer, Laurence, Lydié, Nathalie, Charles, Marie-Aline, Ancel, Pierre-Yves, Jusot, Florence, Rouquette, Alexandra, Priet, Stéphane, Villarroel, Paola Mariela Saba, Fourié, Toscane, Lusivika-Nzinga, Clovis, and Nicol, Jérôme

Subjects
ADULTS, SARS-CoV-2, STAY-at-home orders, INFECTION
Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results